0 217

Cited 7 times in

Efficacy and safety of immunosuppressive agents in the treatment of necrotising scleritis: a retrospective, multicentre study in Korea

DC FieldValueLanguage
dc.contributor.author김태임-
dc.contributor.author이형근-
dc.date.accessioned2018-11-05T16:40:39Z-
dc.date.available2018-11-05T16:40:39Z-
dc.date.issued2016-
dc.identifier.issn0007-1161-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/165037-
dc.description.abstractAIM: To investigate the efficacy and safety of cyclophosphamide and other immunosuppressive agents (ISAs) in the treatment of necrotising scleritis. METHODS: We reviewed the medical records of patients with necrotising scleritis at 11 tertiary care centres in South Korea from 2002 to 2012, treated with ISAs within 3 months of follow-up period. We divided patients into two groups: a group treated with cyclophosphamide (CYC group) and a group treated with other ISAs; azathioprine, ciclosporin, methotrexate and mycophenolate mofetil (OISA group). Main outcome measures evaluated were remission rate, relapse rate, rate of visual loss, steroid-sparing rate, adverse effects and discontinuation of medication due to adverse effects. RESULTS: CYC group had a remission in 95.2% of the patients and OISA group had in 96.3%. Remission rate, relapse rate, visual loss rate and steroid-sparing rate were not significantly different between the two groups (all p>0.05). The median duration of steroid use was longer in CYC group than in other OISA group (55 vs 16 days, p=0.09). The incidence of adverse effects in the CYC group was comparable with that of the OISA group (61.9% vs 41.4%, p=0.15). However, the incidence of leucopenia, haemorrhagic cystitis and discontinuation of medication due to adverse effects were much higher in the CYC group (p<0.001, p<0.001, p=0.05, respectively). CONCLUSION: The efficacy of cyclophosphamide in the treatment of necrotising scleritis was comparable with that of other ISAs. However, the rate of discontinuation due to side effects was much higher in the CYC group.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherBMJ Pub. Group-
dc.relation.isPartOfBRITISH JOURNAL OF OPHTHALMOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleEfficacy and safety of immunosuppressive agents in the treatment of necrotising scleritis: a retrospective, multicentre study in Korea-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Ophthalmology (안과학교실)-
dc.contributor.googleauthorHyun Sun Jeon-
dc.contributor.googleauthorJoon Young Hyon-
dc.contributor.googleauthorMee Kum Kim-
dc.contributor.googleauthorTae-Young Chung-
dc.contributor.googleauthorKyung Chul Yoon-
dc.contributor.googleauthorJae Yong Kim-
dc.contributor.googleauthorKyung-Sun Na-
dc.contributor.googleauthorHyung Joon Kim-
dc.contributor.googleauthorTae-Im Kim-
dc.contributor.googleauthorJong Soo Lee-
dc.contributor.googleauthorHyung Keun Lee-
dc.contributor.googleauthorJong Suk Song-
dc.identifier.doi10.1136/bjophthalmol-2015-307462-
dc.contributor.localIdA01080-
dc.contributor.localIdA01080-
dc.relation.journalcodeJ00412-
dc.identifier.eissn1468-2079-
dc.identifier.pmid26598577-
dc.identifier.urlhttps://bjo.bmj.com/content/100/8/1066.long-
dc.subject.keywordImmunology-
dc.subject.keywordInflammation-
dc.subject.keywordPharmacology-
dc.subject.keywordSclera and Episclera-
dc.subject.keywordTreatment Medical-
dc.contributor.alternativeNameKim, Tae Im-
dc.contributor.affiliatedAuthor김태임-
dc.citation.volume100-
dc.citation.number8-
dc.citation.startPage1066-
dc.citation.endPage1070-
dc.identifier.bibliographicCitationBRITISH JOURNAL OF OPHTHALMOLOGY, Vol.100(8) : 1066-1070, 2016-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.